US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist

1.040
-0.010-0.95%

Close Aug 14 16:00 ET

265.98MMarket Cap-2888P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

208.31%47.4M

14.30%-31.95M

0.63%-140.88M

-818.71%-14.68M

6.23%-45.16M

-6.09%-43.76M

31.47%-37.28M

-1,421.36%-141.77M

-98.48%2.04M

-6.55%-48.16M

Net income from continuing operations

425.03%69.52M

-4,781.76%-48.5M

31.18%-113.87M

-63.82%-47.92M

-10.09%-45.6M

51.96%-21.39M

102.06%1.04M

-4.66%-165.46M

24.73%-29.25M

2.31%-41.42M

Operating gains losses

-206.99%-571K

-45.83%305K

108.12%198K

-911.11%-511K

113.87%332K

-236.76%-186K

330.74%563K

-551.48%-2.44M

-91.63%63K

-4,531.48%-2.39M

Depreciation and amortization

22.85%2.74M

53.39%2.83M

61.98%9.84M

99.79%2.87M

93.96%2.89M

43.81%2.23M

15.67%1.85M

-7.49%6.08M

-35.68%1.44M

2.54%1.49M

Other non cash items

100.10%21K

-114.18%-19K

-2,781.62%-21.88M

-268.63%-86K

-268.89%-304K

-6,024.93%-21.63M

-39.09%134K

-30.43%816K

104.78%51K

-78.52%180K

Change In working capital

-364.79%-27.35M

124.29%10.36M

-1,529.78%-24.95M

11.17%28.28M

54.01%-4.7M

-31.77%-5.89M

-246.97%-42.65M

-101.14%-1.53M

-84.57%25.44M

10.25%-10.21M

-Change in receivables

401.87%5.17M

324.11%15.62M

86.84%-1.29M

-102.92%-582K

61.05%-2.68M

85.90%-1.71M

134.23%3.68M

49.31%-9.81M

60.35%19.97M

33.54%-6.88M

-Change in payables and accrued expense

198.19%8.66M

-36,528.57%-7.65M

-306.15%-9.09M

88.00%-1.3M

-56.17%1.01M

-173.92%-8.82M

-97.82%21K

4.78%4.41M

-350.05%-10.79M

398.19%2.3M

-Change in other working capital

-995.61%-41.64M

105.15%2.39M

-476.20%-14.57M

85.43%30.15M

46.29%-3.02M

209.11%4.65M

-1,756.35%-46.35M

-97.41%3.87M

-89.02%16.26M

-2,152.00%-5.63M

Cash from discontinued investing activities

Operating cash flow

208.31%47.4M

14.30%-31.95M

0.63%-140.88M

-818.71%-14.68M

6.23%-45.16M

-6.09%-43.76M

31.47%-37.28M

-1,421.36%-141.77M

-98.48%2.04M

-6.55%-48.16M

Investing cash flow

Cash flow from continuing investing activities

-127.58%-743K

-100.74%-358K

98.05%176.54M

225.49%68.2M

98.63%57.31M

-93.89%2.69M

1,112.38%48.34M

17.59%89.14M

173.54%20.95M

-17.22%28.85M

Net PPE purchase and sale

65.30%-422K

95.66%-102K

84.13%-4.68M

75.78%-827K

97.11%-289K

86.43%-1.22M

66.98%-2.35M

-244.02%-29.5M

14.97%-3.42M

-512.42%-10.01M

Net intangibles purchase and sale

-1,176.92%-332K

-47.98%-256K

18.44%-199K

--0

---26K

---173K

-17.87%-244K

50.00%-13K

-507.89%-231K

Net business purchase and sale

----

--45.26M

--0

----

--0

Net investment purchase and sale

--0

13.59%135.03M

182.25%68.81M

46.38%57.22M

-178.89%-41.87M

2,074.56%50.86M

40.55%118.88M

199.72%24.38M

7.03%39.09M

Net other investing changes

----

--1.12M

--211K

--376K

----

Cash from discontinued investing activities

Investing cash flow

-127.58%-743K

-100.74%-358K

98.05%176.54M

225.49%68.2M

98.63%57.31M

-93.89%2.69M

1,112.38%48.34M

17.59%89.14M

173.54%20.95M

-17.22%28.85M

Financing cash flow

Cash flow from continuing financing activities

174,985.71%24.51M

14,815.82%29.24M

-93.16%880K

-94.73%74K

-58.95%596K

-99.86%14K

460.00%196K

291.33%12.87M

2,598.08%1.4M

944.60%1.45M

Net common stock issuance

--10K

15,411.17%29.16M

-95.13%624K

-99.93%1K

-69.92%435K

--0

--188K

406.80%12.82M

--1.4M

14,360.00%1.45M

Proceeds from stock option exercised by employees

-85.71%2K

825.00%74K

412.00%256K

812.50%73K

2,583.33%161K

1,300.00%14K

-77.14%8K

-93.41%50K

-84.62%8K

-95.35%6K

Cash from discontinued financing activities

Financing cash flow

174,985.71%24.51M

14,815.82%29.24M

-93.16%880K

-94.73%74K

-58.95%596K

-99.86%14K

460.00%196K

291.33%12.87M

2,598.08%1.4M

944.60%1.45M

Net cash flow

Beginning cash position

18.18%143.53M

34.14%147.02M

-27.73%109.6M

15.31%93.07M

-19.42%80.2M

33.08%121.44M

-27.73%109.6M

146.68%151.67M

80.83%80.71M

80.67%99.52M

Current changes in cash

273.35%71.17M

-127.31%-3.07M

191.88%36.54M

119.68%53.6M

171.37%12.74M

-419.86%-41.05M

119.03%11.25M

-144.27%-39.77M

-76.87%24.4M

-74.89%-17.86M

Effect of exchange rate changes

89.47%-20K

-170.75%-416K

138.15%877K

-92.21%350K

113.51%129K

95.84%-190K

146.30%588K

-729.86%-2.3M

191.31%4.49M

-297.92%-955K

End cash Position

167.68%214.68M

18.18%143.53M

34.14%147.02M

15.31%93.07M

-19.42%80.2M

33.08%121.44M

-27.73%109.6M

80.83%80.71M

Free cash flow

203.65%46.65M

18.83%-32.31M

15.01%-145.76M

-1,018.54%-15.5M

22.17%-45.45M

10.37%-45M

35.29%-39.81M

-8,904.36%-171.51M

-101.07%-1.39M

-24.59%-58.4M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	208.31%47.4M	14.30%-31.95M	0.63%-140.88M	-818.71%-14.68M	6.23%-45.16M	-6.09%-43.76M	31.47%-37.28M	-1,421.36%-141.77M	-98.48%2.04M	-6.55%-48.16M
Net income from continuing operations	425.03%69.52M	-4,781.76%-48.5M	31.18%-113.87M	-63.82%-47.92M	-10.09%-45.6M	51.96%-21.39M	102.06%1.04M	-4.66%-165.46M	24.73%-29.25M	2.31%-41.42M
Operating gains losses	-206.99%-571K	-45.83%305K	108.12%198K	-911.11%-511K	113.87%332K	-236.76%-186K	330.74%563K	-551.48%-2.44M	-91.63%63K	-4,531.48%-2.39M
Depreciation and amortization	22.85%2.74M	53.39%2.83M	61.98%9.84M	99.79%2.87M	93.96%2.89M	43.81%2.23M	15.67%1.85M	-7.49%6.08M	-35.68%1.44M	2.54%1.49M
Other non cash items	100.10%21K	-114.18%-19K	-2,781.62%-21.88M	-268.63%-86K	-268.89%-304K	-6,024.93%-21.63M	-39.09%134K	-30.43%816K	104.78%51K	-78.52%180K
Change In working capital	-364.79%-27.35M	124.29%10.36M	-1,529.78%-24.95M	11.17%28.28M	54.01%-4.7M	-31.77%-5.89M	-246.97%-42.65M	-101.14%-1.53M	-84.57%25.44M	10.25%-10.21M
-Change in receivables	401.87%5.17M	324.11%15.62M	86.84%-1.29M	-102.92%-582K	61.05%-2.68M	85.90%-1.71M	134.23%3.68M	49.31%-9.81M	60.35%19.97M	33.54%-6.88M
-Change in payables and accrued expense	198.19%8.66M	-36,528.57%-7.65M	-306.15%-9.09M	88.00%-1.3M	-56.17%1.01M	-173.92%-8.82M	-97.82%21K	4.78%4.41M	-350.05%-10.79M	398.19%2.3M
-Change in other working capital	-995.61%-41.64M	105.15%2.39M	-476.20%-14.57M	85.43%30.15M	46.29%-3.02M	209.11%4.65M	-1,756.35%-46.35M	-97.41%3.87M	-89.02%16.26M	-2,152.00%-5.63M
Cash from discontinued investing activities
Operating cash flow	208.31%47.4M	14.30%-31.95M	0.63%-140.88M	-818.71%-14.68M	6.23%-45.16M	-6.09%-43.76M	31.47%-37.28M	-1,421.36%-141.77M	-98.48%2.04M	-6.55%-48.16M
Investing cash flow
Cash flow from continuing investing activities	-127.58%-743K	-100.74%-358K	98.05%176.54M	225.49%68.2M	98.63%57.31M	-93.89%2.69M	1,112.38%48.34M	17.59%89.14M	173.54%20.95M	-17.22%28.85M
Net PPE purchase and sale	65.30%-422K	95.66%-102K	84.13%-4.68M	75.78%-827K	97.11%-289K	86.43%-1.22M	66.98%-2.35M	-244.02%-29.5M	14.97%-3.42M	-512.42%-10.01M
Net intangibles purchase and sale	-1,176.92%-332K	-47.98%-256K	18.44%-199K	--0	--0	---26K	---173K	-17.87%-244K	50.00%-13K	-507.89%-231K
Net business purchase and sale	----	----	--45.26M	--0	--0	----	----	--0	--0	--0
Net investment purchase and sale	--0	--0	13.59%135.03M	182.25%68.81M	46.38%57.22M	-178.89%-41.87M	2,074.56%50.86M	40.55%118.88M	199.72%24.38M	7.03%39.09M
Net other investing changes	----	----	--1.12M	--211K	--376K	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-127.58%-743K	-100.74%-358K	98.05%176.54M	225.49%68.2M	98.63%57.31M	-93.89%2.69M	1,112.38%48.34M	17.59%89.14M	173.54%20.95M	-17.22%28.85M
Financing cash flow
Cash flow from continuing financing activities	174,985.71%24.51M	14,815.82%29.24M	-93.16%880K	-94.73%74K	-58.95%596K	-99.86%14K	460.00%196K	291.33%12.87M	2,598.08%1.4M	944.60%1.45M
Net common stock issuance	--10K	15,411.17%29.16M	-95.13%624K	-99.93%1K	-69.92%435K	--0	--188K	406.80%12.82M	--1.4M	14,360.00%1.45M
Proceeds from stock option exercised by employees	-85.71%2K	825.00%74K	412.00%256K	812.50%73K	2,583.33%161K	1,300.00%14K	-77.14%8K	-93.41%50K	-84.62%8K	-95.35%6K
Cash from discontinued financing activities
Financing cash flow	174,985.71%24.51M	14,815.82%29.24M	-93.16%880K	-94.73%74K	-58.95%596K	-99.86%14K	460.00%196K	291.33%12.87M	2,598.08%1.4M	944.60%1.45M
Net cash flow
Beginning cash position	18.18%143.53M	34.14%147.02M	-27.73%109.6M	15.31%93.07M	-19.42%80.2M	33.08%121.44M	-27.73%109.6M	146.68%151.67M	80.83%80.71M	80.67%99.52M
Current changes in cash	273.35%71.17M	-127.31%-3.07M	191.88%36.54M	119.68%53.6M	171.37%12.74M	-419.86%-41.05M	119.03%11.25M	-144.27%-39.77M	-76.87%24.4M	-74.89%-17.86M
Effect of exchange rate changes	89.47%-20K	-170.75%-416K	138.15%877K	-92.21%350K	113.51%129K	95.84%-190K	146.30%588K	-729.86%-2.3M	191.31%4.49M	-297.92%-955K
End cash Position	167.68%214.68M	18.18%143.53M	34.14%147.02M	34.14%147.02M	15.31%93.07M	-19.42%80.2M	33.08%121.44M	-27.73%109.6M	-27.73%109.6M	80.83%80.71M
Free cash flow	203.65%46.65M	18.83%-32.31M	15.01%-145.76M	-1,018.54%-15.5M	22.17%-45.45M	10.37%-45M	35.29%-39.81M	-8,904.36%-171.51M	-101.07%-1.39M	-24.59%-58.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall